Dr. Vinod Mittal, Senior Diabetologist, Delhi Heart and Lung Institute, will talk about the medications which are safe in diabetes kidney disease in this video. In diabetes kidney disease patients, sulphonylureas are avoided. The safest sulphonylureas given is glipizide which is short acting and other is gliclazide. Metformin can be continued till the eGFR is 30. He will further discuss the dose but will also highlight that all sulphonylureas should be avoided.
A disciplined, dedicated and a very competent senior diabetologist. Private practice for more than 20 years with special interest in diabetes care, education, and research. Director of Delhi Diabetes Care Center located in Karol Bagh (Delhi). He is a Senior Consultant Diabetologist at Delhi Heart & Lung Institute.